This inventor holds 2 USPTO granted patents. Top assignees: Bioland Ltd., Centre National De La Recherche Scientifique. Active years: 1987-1998.
Company Filing History:
Years Active: 1987-1998
Title: Gilbert Bonel: Innovator in Antiviral Applications
Introduction
Gilbert Bonel is a notable inventor based in Toulouse, France. He has made significant contributions to the field of biotechnology, particularly in the use of supercritical carbon dioxide for antiviral applications. With a total of 2 patents, Bonel's work showcases his innovative approach to solving complex problems in medical technology.
Latest Patents
One of Bonel's latest patents focuses on the "Uses for a current of supercritical carbon dioxide as an antiviral agent." This invention aims to utilize supercritical carbon dioxide in contact with collagenous tissue, either of human or animal origin, to eliminate viral contamination. The application of this technology is intended for use in implantable supporting tissue prostheses as biomaterials. Another patent involves a "Process for separation of magnesium-based, and possibly fluorine-and," which further highlights his expertise in material science and biotechnology.
Career Highlights
Throughout his career, Bonel has worked with reputable organizations, including Bioland Ltd. and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in the field.
Collaborations
Bonel has collaborated with notable colleagues such as Jacques Fages and Patrick Frayssinet. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Gilbert Bonel's contributions to the field of biotechnology, particularly through his patents on antiviral applications, demonstrate his commitment to advancing medical technology. His innovative work continues to pave the way for new solutions in the fight against viral infections.